Data protection Impressum

Radiotherapy

HeroSupport, a Geneva-based medtech company, has announced that NYU Grossman School of Medicine is the first clinical site in the United States to participate in its SHIELD study evaluating the VENUS SHELL breast immobilization device.

HeroSupport opens its first US clinical site for the SHIELD study

3 August 2026

CHUV has opened a new ambulatory radiology facility in Lausanne to centralize imaging services and modernize its diagnostic infrastructure.

CHUV opens new ambulatory radiology facility to improve patient access and diagnostic capacity

25 November 2025

EBAMed has secured an additional EUR 1.6 million in Series A funding, bringing the total raised to EUR 16 million. This new investment, contributed by CDP Venture Capital and the European Union, supports the development of EBAMed’s groundbreaking CardioKit system for non-invasive treatment of heart arrhythmias using Proton Therapy.

Geneva medtech EBAMed completes financing round with EUR 16 million

27 January 2025

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs healthy controls. The blue-to-white color scale indicates more pronounced tau loads, with pink-white areas representing those with the highest accumulation.

HUG and UNIGE unveil the next frontier in Alzheimer’s diagnosis

15 August 2023